Common symptoms for mumps include:
Mumps can cause several health complications, especially for adults, including:
Mumps spreads from person to person through direct contact with saliva or respiratory droplets from the mouth, nose, or throat. A person infected with mumps can spread the virus by:
A person with mumps can spread the disease up to 2 days before their swelling starts and up to 5 days after their swelling starts.
If you are confirmed to have mumps, you should stay away from other people until the 6th day after your swelling started. This will help make sure that you do not spread mumps to others.
If you think you or someone in your family may have mumps because you or they have symptoms, have not been vaccinated against mumps, and/or have been traveling:
If you think you have been exposed to someone with mumps:
The mumps vaccine is safe and works well in preventing mumps. Everyone including children, teenagers, and adults should get two doses of mumps vaccine if they were never vaccinated.
One dose of a mumps vaccine is about 78% effective, and two doses are about 88% effective at preventing mumps. However, vaccine effectiveness can vary between individuals, and protection may wane over time. Because of this, even fully vaccinated individuals who develop symptoms of mumps should still be tested for mumps.
There are two types of mumps vaccines:
Mumps can be prevented with MMR or MMRV vaccines. California requires that children get at least one dose of the MMR or MMRV vaccine before starting school or childcare.
The American Academy of Pediatrics (AAP) recommends that children get two doses of MMR or MMRV vaccine:
Other vaccines can be given at the same time as the MMR or MMRV vaccine.
Who SHOULD get the vaccine:
Who should NOT get the vaccine:
Who should talk to their doctor in case they need to wait to get the vaccine:
Talk to your doctor if you have any of these health conditions or other precautions for vaccination. Learn more about who should get the MMR or MMRV vaccine.
If you have insurance:
If you are uninsured or underinsured:
Locating Vaccine Clinics:
If you are unsure of your mumps vaccination status, you can request a copy of your records.
To request your record:
If your vaccines are not listed, ask your doctor, pharmacist, or vaccine provider for a copy of your vaccine records. You can also ask them to add your vaccines to the California Immunization Registry (CAIR).
Other tips to find your records:
Mumps cases continue to occur in the United States and can lead to serious complications. It is important to consider mumps when evaluating any vaccinated or unvaccinated patient who presents any of the traditional mumps symptoms.
Please contact the LAC DPH Vaccine-Preventable Disease Control Program to report a case or obtain any other technical assistance with specimen collection or completion of forms for mumps or any other vaccine-preventable disease.
Suspected or confirmed mumps cases are to be reported within 7 calendar days from identification by electronic transmission (email or digital fax) or telephone per Title 17, California Code of Regulations (CCR), Section 2500.
Please send the patient’s medical records and any available immunization records and/or laboratory results via secure email or fax.
Consultation with VPDC is required before sending specimens to the Public Health Laboratory. Follow the Checklist for Managing Patients Suspected of Having Mumps for specific instructions.
If a commercial lab cannot perform testing, please call the Los Angeles County Department of Public Health Vaccine-Preventable Disease Control Program at 213-351-7800 for assistance.
There is no post-exposure prophylaxis available for mumps. However, vaccination after exposure with mumps-containing vaccines (MMR or MMRV) is not harmful and may possibly prevent subsequent disease if re-exposed.
There is no treatment for mumps. Mumps generally self-resolves, and therapy is symptom-based and supportive, such as the use of analgesics as needed. Standard immunoglobulin or gamma-globulin preparations do not appear to be effective treatment options based on the available research to date.
The American Academy of Pediatrics (AAP) and the American Academy of Family Physicians (AAFP) recommend that persons who do not have presumptive evidence of immunity should get vaccinated. Vaccination is the best way to prevent mumps and complications from disease.
MMR and MMRV Vaccine Recommendations for Children and Adults
| Mumps-Containing Vaccines and Brands | Number of Doses | Age for Primary Series | Recommended Age | Dose & Route | |
|---|---|---|---|---|---|
| Dose 1 | Dose 2 | ||||
| M-M-R II® | PRIORIX®
(Measles-Mumps-Rubella)* Merck | GlaxoSmithKline (GSK) |
2** | 12-15 mos |
4-6 yrs and/or 4 wks after Dose 1 | ≥12 mos** | 0.5 mL Subcutaneous (SQ) or Intramuscular (IM)***,† |
| ≥ 19 yrs | At least 4 wks after Dose 1 | ||||
| ProQuad® (Measles-Mumps-Rubella-Varicella)‡ Merck |
2 | 12-47 mos | 4-6 yrs and/or at least 3 mos after Dose 1 | 12 mos-12 yrs | 0.5 mL IM or SQ† |
| *M-M-R®II and PRIORIX® are fully interchangeable for all indications for which MMR vaccination is recommended. **An additional dose may be indicated in mumps outbreak situations and travel where mumps exposure is likely. Doses given before 12 months are invalid. May receive 1st dose of MMR 4 days before 1st birthday. ***PRIORIX® should only be given subcutaneously. †The preferred injection site in small children is the anterolateral aspect of the thigh. The posterior triceps aspect of the upper arm is the preferred site for older children, adolescents and adults. ‡ProQuad® is only licensed for use in children 12 months through 12 years of age. It may be given at the same time as other vaccines. ProQuad® is associated with a higher risk for fever and febrile seizures in children 12-23 months of age. |
|||||
MMR Vaccine Recommendations for Mumps Outbreaks and High Risk Settings
A third dose of a mumps virus-containing vaccine may be recommended during mumps outbreaks for individuals who have already received 2 doses, but who are identified by public health authorities as part of a group at increased risk for mumps. This recommendation specifically pertains to mumps outbreaks, not mumps exposure. In general, adults without presumptive evidence of immunity should receive at least 1 dose of the MMR vaccine, and certain adults may need 2 doses depending on their risk factors.
Pregnancy is a contraindication to vaccination with live virus vaccines, including MMR. The American College of Obstetricians & Gynecologists (ACOG) recommends avoiding pregnancy for 4 weeks after receipt of MMR.
Administration Data: California healthcare providers are required to report data on all valid immunizations that they administer to their patients into the California Immunization Registry (CAIR) within 2 weeks of administration per AB 1797.
Administration Errors: Healthcare providers are strongly recommended to report all vaccine administration errors to the Institute for Safe Medication Practices.
Adverse Events: Healthcare providers are required to report any adverse event on the reportable events list to the Vaccine Adverse Event Reporting System (VAERS) per HR 5546.
Storage and Handling: For general recommendations and guidance access the Vaccine Storage and Handling Job Aids.